A.Vogel Echinaforce Sore Throat Spray provides cooling and soothing relief against painful and swollen tonsils, pharyngitis and general throat pain and inflammation . Studies show that its polysaccharides and polyacetylenes components are capable of stimulating the phagocytosis of macrophages and the production of cytokines like interleukine-1, interleukine-6 (also called interferon beta), interleukine-10 and TNF alpha factor. Thus, proving its ability to strengthen our immune system during cases of infections.
What Are the Key Health Benefits Associated with A.Vogel Echinaforce Sore Throat Spray?
- Potent immune support
- Has anti-fungal and anti-bacterial properties
- Relieves symptoms of upper respiratory tract infections
- Reduces painful inflammation and infection of the throat,/li>
Each Spray Contains Tincture of:
Echinacea (Echinacea purpurea) herb* (ratio 1:12)|189.9mg
equivalent to 15.8mg dried herb
Echinacea (Echinacea purpurea) root* (ratio 1:11)|10.01mg
equivalent to 0.9mg dried root
Sage (Salvia officinalis) herb* (ratio 1:17)|94.6mg
equivalent to 5.6mg dried herb
*Certified organically grown by: Bio Suisse
Non-Medicinal Ingredients: Sorbitol solution , alcohol , lecithin , sucrose fatty acid esters , peppermint oil.
Adults and children over 12 years old: Take 2 sprays (0.220mL), 6 to 10 times daily. Spray in back of throat as needed.
Caution:
Consult a healthcare practitioner prior to use if you have auto-immune disorders or if you are taking immunosuppressants, or if you have a progressive systemic disease such as: tuberculosis, leucosis, collagenosis, multiple sclerosis, AIDS, HIV infection or if you are taking hypoglycemic, anticonvulsant or sedative drugs.
Do not use during pregnancy or breastfeeding.
Do not use if you have an allergy to Asteraceae/Compositae (daisy) family and in case of known allergy to any of the ingredients in the product.
If symptoms persist or worsen for more than 7 days, consult a healthcare practitioner.
Akhondzadeh S, Noroozian M, Mohammadi M et al. Salvia officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomized and placebo-controlled trial. J Clin Pharm Ther 2003 Feb;28(1):53-9.
Burger Ra, Torres AR, Warren RP et al. Echinacea-induced cytokine by human macrophages. Int J Immunopharmacol 1997;19(7):371-9.
Lin Z, Neamati N, Zhao H et al. Chicoric acid analogues as HIV-1 integrase inhibitors. J Med Chem 1999;42(8):1401-14.
Facino RM, Carini M, Aldini G et al. Echinacoside and caffeoyl conjugates protect collagen from free radical-induced degradation: a potential use of Echinacea extracts in the prevention of skin photodamage. Planta Med 1995;61(6):510-4.
